{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:37:10Z","timestamp":1787618230177,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The like-Smith (LSM) family is a group of RNA-binding proteins involved in RNA metabolism. However, their involvement in tumors, particularly skin cutaneous melanoma (SKCM), is not fully understood. In this study, we focused on the expression profiles and prognostic values of the LSM family in SKCM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Raw data were downloaded from The Cancer Genome Atlas. The expression profile and prognostic value of LSM genes in SKCM were explored using the GEPIA, cBioPortal, and HPA databases. Protein\u2013protein and gene\u2013gene interaction analyses were performed using STRING and GeneMANIA. Enrichment and Cox regression analysis were conducted using R software. The TISIDB database was used to explore the relationship between LSMs and immunomodulators. Receiver operating characteristic curves and nomogram models were constructed to validate prognostic values.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>mRNA and protein expression levels of LSM2, LSM4, and LSM12 were significantly elevated in SKCM. The upregulated mRNA expression of LSM2 (<jats:italic>p<\/jats:italic>\u2009=\u20090.0013) and LSM4 (<jats:italic>p<\/jats:italic>\u2009=\u20090.0043) was significantly correlated with poor overall survival in patients with SKCM, whereas only LSM2 (<jats:italic>p<\/jats:italic>\u2009=\u20090.049) overexpression was markedly associated with worse disease-free survival. LSM2 overexpression was an independent risk factor (<jats:italic>p<\/jats:italic>\u2009=\u20090.013) and was confirmed to have a high prognostic value in SKCM using the receiver operating characteristic curve (AUC\u2009=\u20090.942) and nomogram models. All LSM genes were identified as genomic mutations, whereas alteration of LSM2 (<jats:italic>p<\/jats:italic>\u2009=\u20090.0153) significantly affected the overall survival in patients with SKCM. Significant correlations were observed between LSM family expression, immune cell infiltration, and immunomodulator. Furthermore, function and pathway enrichment analysis showed that the LSM family was mainly RNA binding proteins and involved in RNA splicing and degradation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Expression profiles and prognostic values of LSM in SKCM were inconsistent. Among the LSM family, only LSM2 may serve as a potential poor prognosticator and immunotherapeutic target of SKCM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-022-01395-6","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T13:29:38Z","timestamp":1668259778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Expression profile and prognostic values of LSM family in skin cutaneous melanoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiaofang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9442-5864","authenticated-orcid":false,"given":"Zili","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"issue":"1","key":"1395_CR1","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41467-020-15546-9","volume":"11","author":"VW Rebecca","year":"2020","unstructured":"Rebecca VW, Somasundaram R, Herlyn M. Pre-clinical modeling of cutaneous melanoma. Nat Commun. 2020;11(1):2858.","journal-title":"Nat Commun"},{"issue":"11","key":"1395_CR2","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1245\/s10434-021-09866-3","volume":"28","author":"O Ahmadi","year":"2021","unstructured":"Ahmadi O, Das M, Hajarizadeh B, Mathy JA. Impact of shave biopsy on diagnosis and management of cutaneous melanoma: a systematic review and meta-analysis. Ann Surg Oncol. 2021;28(11):6168\u201376.","journal-title":"Ann Surg Oncol"},{"key":"1395_CR3","doi-asserted-by":"publisher","first-page":"101753","DOI":"10.1016\/j.redox.2020.101753","volume":"37","author":"LR Arslanbaeva","year":"2020","unstructured":"Arslanbaeva LR, Santoro MM. Adaptive redox homeostasis in cutaneous melanoma. Redox Biol. 2020;37:101753.","journal-title":"Redox Biol"},{"issue":"4","key":"1395_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0889-8588(05)70023-X","volume":"12","author":"WH McCarthy","year":"1998","unstructured":"McCarthy WH, Shaw HM. The surgical treatment of primary melanoma. Hematol\/Oncol Clin N Am. 1998;12(4):797\u2013805.","journal-title":"Hematol\/Oncol Clin N Am."},{"issue":"1","key":"1395_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00262-017-2061-4","volume":"67","author":"S Diem","year":"2018","unstructured":"Diem S, Hasan Ali O, Ackermann CJ, Bomze D, Koelzer VH, Jochum W, Speiser DE, Mertz KD, Flatz L. Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease. Cancer Immunol Immunother: CII. 2018;67(1):39\u201345.","journal-title":"Cancer Immunol Immunother: CII"},{"key":"1395_CR6","doi-asserted-by":"crossref","unstructured":"Bai R, Huang H. Temporal trends in the incidence and mortality of skin malignant melanoma in China from 1990 to 2019. 2021; 2021:9989824.","DOI":"10.1155\/2021\/9989824"},{"key":"1395_CR7","doi-asserted-by":"crossref","unstructured":"Lee KA, Nathan P. Cutaneous melanoma: a review of systemic therapies. Acta dermato-venereologica. 2020; 100(11):adv00141.","DOI":"10.2340\/00015555-3496"},{"issue":"4","key":"1395_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s13555-022-00709-x","volume":"12","author":"AS Farberg","year":"2022","unstructured":"Farberg AS, Marson JW, Glazer A, Litchman GH, Svoboda R, Winkelmann RR, Brownstone N, Rigel DS. Expert consensus on the use of prognostic gene expression profiling tests for the management of cutaneous melanoma: consensus from the skin cancer prevention working group. Dermatol Ther. 2022;12(4):807\u201323.","journal-title":"Dermatol Ther"},{"key":"1395_CR9","doi-asserted-by":"crossref","unstructured":"Valenti F, Falcone I. Precision medicine and melanoma: multi-omics approaches to monitoring the immunotherapy response. 2021; 22(8).","DOI":"10.3390\/ijms22083837"},{"issue":"5","key":"1395_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/DAD.0b013e31828a2ec5","volume":"36","author":"O Abbas","year":"2014","unstructured":"Abbas O, Miller DD, Bhawan J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers. Am J Dermatopathol. 2014;36(5):363\u201379.","journal-title":"Am J Dermatopathol"},{"issue":"7","key":"1395_CR11","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/iub.2258","volume":"72","author":"Q Wan","year":"2020","unstructured":"Wan Q, Jin L, Su Y, Liu Y, Li C, Wang Z. Development and validation of autophagy-related-gene biomarker and nomogram for predicting the survival of cutaneous melanoma. IUBMB Life. 2020;72(7):1364\u201378.","journal-title":"IUBMB Life"},{"issue":"7","key":"1395_CR12","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.7150\/ijms.54747","volume":"18","author":"X Wu","year":"2021","unstructured":"Wu X, Wang X, Zhao Y, Li K, Yu B, Zhang J. Granzyme family acts as a predict biomarker in cutaneous melanoma and indicates more benefit from anti-PD-1 immunotherapy. Int J Med Sci. 2021;18(7):1657\u201369.","journal-title":"Int J Med Sci"},{"issue":"Suppl 1","key":"1395_CR13","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1134\/S0006297921140042","volume":"86","author":"NV Lekontseva","year":"2021","unstructured":"Lekontseva NV, Stolboushkina EA, Nikulin AD. Diversity of LSM family proteins: similarities and differences. Biochemistry Biokhimiia. 2021;86(Suppl 1):S38-s49.","journal-title":"Biochemistry Biokhimiia"},{"issue":"6","key":"1395_CR14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1261\/rna.066175.118","volume":"24","author":"AJ Roth","year":"2018","unstructured":"Roth AJ, Shuman S, Schwer B. Defining essential elements and genetic interactions of the yeast Lsm2-8 ring and demonstration that essentiality of Lsm2-8 is bypassed via overexpression of U6 snRNA or the U6 snRNP subunit Prp24. RNA (New York, NY). 2018;24(6):853\u201364.","journal-title":"RNA (New York, NY)"},{"issue":"5","key":"1395_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4161\/rna.29144","volume":"11","author":"O Weichenrieder","year":"2014","unstructured":"Weichenrieder O. RNA binding by Hfq and ring-forming (L)Sm proteins: a trade-off between optimal sequence readout and RNA backbone conformation. RNA Biol. 2014;11(5):537\u201349.","journal-title":"RNA Biol"},{"issue":"Pt 24","key":"1395_CR16","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1242\/jcs.019943","volume":"120","author":"MP Spiller","year":"2007","unstructured":"Spiller MP, Reijns MA, Beggs JD. Requirements for nuclear localization of the Lsm2-8p complex and competition between nuclear and cytoplasmic Lsm complexes. J Cell Sci. 2007;120(Pt 24):4310\u201320.","journal-title":"J Cell Sci"},{"issue":"10","key":"1395_CR17","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1261\/rna.1650109","volume":"15","author":"A Chowdhury","year":"2009","unstructured":"Chowdhury A, Tharun S. Activation of decapping involves binding of the mRNA and facilitation of the post-binding steps by the Lsm1-7-Pat1 complex. RNA (New York, NY). 2009;15(10):1837\u201348.","journal-title":"RNA (New York, NY)"},{"issue":"16","key":"1395_CR18","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1128\/MCB.20.16.5939-5946.2000","volume":"20","author":"C Bonnerot","year":"2000","unstructured":"Bonnerot C, Boeck R, Lapeyre B. The two proteins Pat1p (Mrt1p) and Spb8p interact in vivo, are required for mRNA decay, and are functionally linked to Pab1p. Mol Cell Biol. 2000;20(16):5939\u201346.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1395_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S1097-2765(01)00395-1","volume":"8","author":"S Tharun","year":"2001","unstructured":"Tharun S, Parker R. Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol Cell. 2001;8(5):1075\u201383.","journal-title":"Mol Cell"},{"key":"1395_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0076-6879(08)02603-7","volume":"448","author":"S Tharun","year":"2008","unstructured":"Tharun S. Purification and analysis of the decapping activator Lsm1p-7p-Pat1p complex from yeast. Methods Enzymol. 2008;448:41\u201355.","journal-title":"Methods Enzymol"},{"key":"1395_CR21","doi-asserted-by":"crossref","unstructured":"Montemayor EJ, Virta JM, Hayes SM, Nomura Y. Molecular basis for the distinct cellular functions of the Lsm1\u20137 and Lsm2\u20138 complexes. 2020; 26(10):1400\u20131413.","DOI":"10.1261\/rna.075879.120"},{"key":"1395_CR22","doi-asserted-by":"crossref","unstructured":"Zhang J, Guan X, Shah K, Yan J. Lsm12 is an NAADP receptor and a two-pore channel regulatory protein required for calcium mobilization from acidic organelles. 2021; 12(1):4739.","DOI":"10.1038\/s41467-021-24735-z"},{"key":"1395_CR23","doi-asserted-by":"crossref","unstructured":"Zuo Z, Roux M, Rodriguez E, Petersen M. mRNA Decapping Factors LSM1 and PAT Paralogs are involved in turnip mosaic virus viral infection. 2022; 35(2):125\u2013130.","DOI":"10.1094\/MPMI-09-21-0220-SC"},{"issue":"8","key":"1395_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1261\/rna.052209.115","volume":"21","author":"J Jungfleisch","year":"2015","unstructured":"Jungfleisch J, Chowdhury A, Alves-Rodrigues I, Tharun S, D\u00edez J. The Lsm1-7-Pat1 complex promotes viral RNA translation and replication by differential mechanisms. RNA (New York, NY). 2015;21(8):1469\u201379.","journal-title":"RNA (New York, NY)"},{"issue":"14","key":"1395_CR25","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/sj.onc.1210002","volume":"26","author":"KL Streicher","year":"2007","unstructured":"Streicher KL, Yang ZQ, Draghici S, Ethier SP. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon. Oncogene. 2007;26(14):2104\u201314.","journal-title":"Oncogene"},{"issue":"1","key":"1395_CR26","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1038\/oncsis.2015.45","volume":"5","author":"EC Little","year":"2016","unstructured":"Little EC, Camp ER, Wang C, Watson PM, Watson DK, Cole DJ. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis. 2016;5(1):e182.","journal-title":"Oncogenesis"},{"issue":"6","key":"1395_CR27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.bjc.6600163","volume":"86","author":"S Takahashi","year":"2002","unstructured":"Takahashi S, Suzuki S, Inaguma S, Cho YM, Ikeda Y, Hayashi N, Inoue T, Sugimura Y, Nishiyama N, Fujita T, et al. Down-regulation of Lsm1 is involved in human prostate cancer progression. Br J Cancer. 2002;86(6):940\u20136.","journal-title":"Br J Cancer"},{"key":"1395_CR28","unstructured":"Gu XH, Lu Y, Ma D, Liu XS, Guo SW. Model of aberrant DNA methylation patterns and its applications in epithelial ovarian cancer.. Zhonghua fu chan ke za zhi. 2009; 44(10):754\u20139."},{"key":"1395_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fneur.2020.00233","volume":"11","author":"Y Tao","year":"2020","unstructured":"Tao Y, Han Y, Yu L, Wang Q, Leng SX, Zhang H. The predicted key molecules, functions, and pathways that bridge mild cognitive impairment (MCI) and Alzheimer\u2019s disease (AD). Front Neurol. 2020;11:233.","journal-title":"Front Neurol"},{"key":"1395_CR30","doi-asserted-by":"crossref","unstructured":"Ye Q, Singh S, Qian PR, Guo NL. Immune-omics networks of CD27, PD1, and PDL1 in non-small cell lung cancer. 2021; 13(17).","DOI":"10.3390\/cancers13174296"},{"key":"1395_CR31","doi-asserted-by":"crossref","unstructured":"Ta HDK, Wang WJ, Phan NN, An Ton NT, Anuraga G. Potential therapeutic and prognostic values of LSM family genes in breast cancer. 2021; 13(19).","DOI":"10.3390\/cancers13194902"},{"issue":"4","key":"1395_CR32","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.21037\/tcr-20-3056","volume":"10","author":"Z Chen","year":"2021","unstructured":"Chen Z, Han C, Zhou X, Wang X, Liao X, He Y, Mo S, Li X, Zhu G, Ye X, et al. Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma. Transl Cancer Res. 2021;10(4):1744\u201360.","journal-title":"Transl Cancer Res."},{"key":"1395_CR33","doi-asserted-by":"publisher","first-page":"804916","DOI":"10.3389\/fgene.2021.804916","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Lin YH, Liu GQ, Huang JE, Wei W, Yang ZH, Hu YM, Xie JH, Yu HZ. Clinical significance and potential role of LSM4 overexpression in hepatocellular carcinoma: an integrated analysis based on multiple databases. Front Genet. 2021;12:804916.","journal-title":"Front Genet"},{"issue":"W1","key":"1395_CR34","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1395_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"1395_CR36","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics (Oxford, England). 2019;35(20):4200\u20132.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"4","key":"1395_CR37","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jaad.2020.07.078","volume":"84","author":"S Guhan","year":"2021","unstructured":"Guhan S, Boland G, Tanabe K, Lin W, Reddy B, Hawryluk EB, Sober AJ, Tsao H. Surgical delay and mortality for primary cutaneous melanoma. J Am Acad Dermatol. 2021;84(4):1089\u201391.","journal-title":"J Am Acad Dermatol"},{"key":"1395_CR38","doi-asserted-by":"crossref","unstructured":"Martinez-Garcia MA, Campos-Rodriguez F, Almendros I. Cancer and sleep apnea: cutaneous melanoma as a case study. 2019; 200(11):1345\u201353.","DOI":"10.1164\/rccm.201903-0577PP"},{"issue":"12","key":"1395_CR39","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1158\/1535-7163.MCT-17-0461","volume":"16","author":"S Chan","year":"2017","unstructured":"Chan S, Sridhar P, Kirchner R, Lock YJ, Herbert Z, Buonamici S, Smith P, Lieberman J, Petrocca F. Basal-A triple-negative breast cancer cells selectively rely on RNA splicing for survival. Mol Cancer Ther. 2017;16(12):2849\u201361.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1395_CR40","doi-asserted-by":"publisher","first-page":"15610","DOI":"10.1038\/s41598-021-95068-6","volume":"11","author":"J Yin","year":"2021","unstructured":"Yin J, Lin C, Jiang M, Tang X, Xie D, Chen J, Ke R. CENPL, ISG20L2, LSM4, MRPL3 are four novel hub genes and may serve as diagnostic and prognostic markers in breast cancer. Sci Rep. 2021;11(1):15610.","journal-title":"Sci Rep"},{"key":"1395_CR41","doi-asserted-by":"crossref","unstructured":"Wang J, Wu S. Potential prognosis and diagnostic value of AKT3, LSM12, MEF2C, and RAB30 in exosomes in colorectal cancer on spark framework. 2021; 2021:8218043.","DOI":"10.1155\/2021\/8218043"},{"key":"1395_CR42","doi-asserted-by":"crossref","unstructured":"Noblejas-L\u00f3pez MDM, L\u00f3pez-Cade I. Genomic Mapping of splicing-related genes identify amplifications in LSM1, CLNS1A, and ILF2 in luminal breast cancer. 2021; 13(16).","DOI":"10.3390\/cancers13164118"},{"key":"1395_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1471-2164-7-268","volume":"7","author":"H Lyng","year":"2006","unstructured":"Lyng H, Br\u00f8vig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundf\u00f8r K, Kristensen GB, Stokke T. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics. 2006;7:268.","journal-title":"BMC Genomics"},{"key":"1395_CR44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/1471-2407-12-396","volume":"12","author":"S Tomei","year":"2012","unstructured":"Tomei S, Marchetti I, Zavaglia K, Lessi F, Apollo A, Aretini P, Di Coscio G, Bevilacqua G, Mazzanti C. A molecular computational model improves the preoperative diagnosis of thyroid nodules. BMC Cancer. 2012;12:396.","journal-title":"BMC Cancer"},{"issue":"1","key":"1395_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36\u201350.","journal-title":"Cell Metab"},{"issue":"18","key":"1395_CR46","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Can Res. 2019;79(18):4557\u201366.","journal-title":"Can Res"},{"issue":"2","key":"1395_CR47","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cell.2020.03.053","volume":"181","author":"O Rozenblatt-Rosen","year":"2020","unstructured":"Rozenblatt-Rosen O, Regev A, Oberdoerffer P, Nawy T, Hupalowska A, Rood JE, Ashenberg O, Cerami E, Coffey RJ, Demir E, et al. The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution. Cell. 2020;181(2):236\u201349.","journal-title":"Cell"},{"key":"1395_CR48","doi-asserted-by":"crossref","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T. RNA-binding proteins in tumor progression. 2020; 13(1):90.","DOI":"10.1186\/s13045-020-00927-w"},{"key":"1395_CR49","doi-asserted-by":"crossref","unstructured":"Mungenast F, Fernando A. Next-generation digital histopathology of the tumor microenvironment. 2021; 12(4).","DOI":"10.3390\/genes12040538"},{"issue":"3","key":"1395_CR50","first-page":"253","volume":"21","author":"L Corcos","year":"2005","unstructured":"Corcos L, Solier S. Alternative mRNA splicing, pathology and molecular therapeutics. Med Sci: M\/S. 2005;21(3):253\u201360.","journal-title":"Med Sci: M\/S"},{"issue":"6","key":"1395_CR51","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1165\/rcmb.2007-0205OC","volume":"38","author":"PM Watson","year":"2008","unstructured":"Watson PM, Miller SW, Fraig M, Cole DJ, Watson DK, Boylan AM. CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes. Am J Respir Cell Mol Biol. 2008;38(6):671\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1395_CR52","doi-asserted-by":"publisher","first-page":"568469","DOI":"10.3389\/fonc.2020.568469","volume":"10","author":"C Mei","year":"2020","unstructured":"Mei C, Song PY, Zhang W, Zhou HH, Li X, Liu ZQ. Aberrant RNA splicing events driven by mutations of RNA-binding proteins as indicators for skin cutaneous melanoma prognosis. Front Oncol. 2020;10:568469.","journal-title":"Front Oncol"},{"issue":"6","key":"1395_CR53","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1091\/mbc.e04-02-0116","volume":"15","author":"CF Fernandez","year":"2004","unstructured":"Fernandez CF, Pannone BK, Chen X, Fuchs G, Wolin SL. An Lsm2-Lsm7 complex in Saccharomyces cerevisiae associates with the small nucleolar RNA snR5. Mol Biol Cell. 2004;15(6):2842\u201352.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"1395_CR54","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12885-021-08442-y","volume":"21","author":"X Gao","year":"2021","unstructured":"Gao X, Zhao C, Zhang N, Cui X, Ren Y, Su C, Wu S, Yao Z, Yang J. Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients. BMC Cancer. 2021;21(1):786.","journal-title":"BMC Cancer"},{"key":"1395_CR55","doi-asserted-by":"crossref","unstructured":"Koedoot E, van Steijn E, Vermeer M, Gonz\u00e1lez-Prieto R, Vertegaal ACO, Martens JWM, Le D\u00e9v\u00e9dec SE, van de Water B. Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention. J Exp Clin Cancer Res: CR. 2021;40(1):82.","DOI":"10.1186\/s13046-021-01863-4"},{"issue":"6","key":"1395_CR56","doi-asserted-by":"publisher","first-page":"474","DOI":"10.21037\/atm-21-452","volume":"9","author":"L Yang","year":"2021","unstructured":"Yang L, Zhang R, Guo G, Wang G, Wen Y, Lin Y, Zhang X, Yu X, Huang Z, Zhao D, et al. Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein. Ann Transl Med. 2021;9(6):474.","journal-title":"Ann Transl Med"},{"issue":"2","key":"1395_CR57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3892\/ol.2011.505","volume":"3","author":"T Anchi","year":"2012","unstructured":"Anchi T, Tamura K, Furihata M, Satake H, Sakoda H, Kawada C, Kamei M, Shimamoto T, Fukuhara H, Fukata S, et al. SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression. Oncol Lett. 2012;3(2):264\u20138.","journal-title":"Oncol Lett"},{"key":"1395_CR58","doi-asserted-by":"publisher","first-page":"584964","DOI":"10.3389\/fpubh.2020.584964","volume":"8","author":"J Liu","year":"2020","unstructured":"Liu J, Ma T, Gao M, Liu Y, Liu J, Wang S, Xie Y, Wen Q, Wang L, Cheng J, et al. Proteomic characterization of proliferation inhibition of well-differentiated laryngeal squamous cell carcinoma cells under below-background radiation in a deep underground environment. Front Public Health. 2020;8:584964.","journal-title":"Front Public Health"},{"issue":"42","key":"1395_CR59","doi-asserted-by":"publisher","first-page":"15166","DOI":"10.1073\/pnas.1409791111","volume":"111","author":"S Perez-Sant\u00e1ngelo","year":"2014","unstructured":"Perez-Sant\u00e1ngelo S, Mancini E, Francey LJ, Schlaen RG, Chernomoretz A, Hogenesch JB, Yanovsky MJ. Role for LSM genes in the regulation of circadian rhythms. Proc Natl Acad Sci USA. 2014;111(42):15166\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1395_CR60","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1105\/tpc.112.103697","volume":"24","author":"C Perea-Resa","year":"2012","unstructured":"Perea-Resa C, Hern\u00e1ndez-Verdeja T, L\u00f3pez-Cobollo R, del Mar CM, Salinas J. LSM proteins provide accurate splicing and decay of selected transcripts to ensure normal Arabidopsis development. Plant Cell. 2012;24(12):4930\u201347.","journal-title":"Plant Cell"},{"issue":"1","key":"1395_CR61","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2018.01.088","volume":"23","author":"M Seiler","year":"2018","unstructured":"Seiler M, Peng S, Agrawal AA, Palacino J, Teng T, Zhu P, Smith PG, Buonamici S, Yu L. Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Rep. 2018;23(1):282\u201396.","journal-title":"Cell Rep"},{"issue":"7592","key":"1395_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47\u201352.","journal-title":"Nature"},{"issue":"6","key":"1395_CR63","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","volume":"150","author":"M Imielinski","year":"2012","unstructured":"Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012;150(6):1107\u201320.","journal-title":"Cell"},{"issue":"11","key":"1395_CR64","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/s41388-019-1138-2","volume":"39","author":"X Dong","year":"2020","unstructured":"Dong X, Chen R. Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy. Oncogene. 2020;39(11):2231\u201342.","journal-title":"Oncogene"},{"issue":"7653","key":"1395_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K, Patch AM, Kakavand H, Alexandrov LB, Burke H, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545(7653):175\u201380.","journal-title":"Nature"},{"issue":"4","key":"1395_CR66","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/CMR.0000000000000071","volume":"24","author":"Y Kong","year":"2014","unstructured":"Kong Y, Krauthammer M, Halaban R. Rare SF3B1 R625 mutations in cutaneous melanoma. Melanoma Res. 2014;24(4):332\u20134.","journal-title":"Melanoma Res"},{"key":"1395_CR67","doi-asserted-by":"publisher","first-page":"44634","DOI":"10.1038\/srep44634","volume":"7","author":"Y Pan","year":"2017","unstructured":"Pan Y, Liu H, Wang Y, Kang X, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, et al. Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep. 2017;7:44634.","journal-title":"Sci Rep"},{"issue":"3","key":"1395_CR68","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s12079-021-00619-1","volume":"15","author":"S Yu","year":"2021","unstructured":"Yu S, Hu Q, Fan K, Yang C, Gao Y. CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling. J Cell Commun Signal. 2021;15(3):383\u201392.","journal-title":"J Cell Commun Signal"},{"issue":"6","key":"1395_CR69","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/2211-5463.13175","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Qiu J, Zuo D, Yuan Y, Qiu Y, Qiao L, He W, Li B, Yuan Y. SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial-mesenchymal transition. FEBS Open Bio. 2021;11(6):1757\u201370.","journal-title":"FEBS Open Bio"},{"issue":"4","key":"1395_CR70","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4161\/cbt.3.4.724","volume":"3","author":"Y Shi","year":"2004","unstructured":"Shi Y, Zhang Y, Zhao Y, Hong L, Liu N, Jin X, Pan Y, Fan D. Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein. Cancer Biol Ther. 2004;3(4):377\u201381.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"1395_CR71","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3748\/wjg.v9.i5.894","volume":"9","author":"YM Zhang","year":"2003","unstructured":"Zhang YM, Zhao YQ, Pan YL, Shi YQ, Jin XH, Yi H, Fan DM. Effect of ZNRD1 gene antisense RNA on drug resistant gastric cancer cells. World J Gastroenterol. 2003;9(5):894\u20138.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1395_CR72","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/exd.13263","volume":"26","author":"JK Tietze","year":"2017","unstructured":"Tietze JK, Angelova D, Heppt MV, Ruzicka T, Berking C. Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy. Exp Dermatol. 2017;26(7):622\u20139.","journal-title":"Exp Dermatol"},{"key":"1395_CR73","doi-asserted-by":"crossref","unstructured":"Klebanoff CA, Gattinoni L, Restifo NP. Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? J Immunother (Hagerstown, Md : 1997). 2012; 35(9):651\u201360.","DOI":"10.1097\/CJI.0b013e31827806e6"},{"issue":"27","key":"1395_CR74","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, et al. Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci USA. 2005;102(27):9571\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1395_CR75","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1172\/JCI32103","volume":"118","author":"C Berger","year":"2008","unstructured":"Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Investig. 2008;118(1):294\u2013305.","journal-title":"J Clin Investig"},{"key":"1395_CR76","doi-asserted-by":"crossref","unstructured":"Zhou J, Dudley ME, Rosenberg SA, Robbins PF. Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother (Hagerstown, Md : 1997). 2005; 28(1):53\u201362.","DOI":"10.1097\/00002371-200501000-00007"},{"issue":"8","key":"1395_CR77","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807\u201321.","journal-title":"Cell Mol Immunol"},{"key":"1395_CR78","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol. 2021;16:223\u201349.","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"1395_CR79","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/2326-6066.CIR-17-0122","volume":"5","author":"Y Masugi","year":"2017","unstructured":"Masugi Y, Nishihara R, Hamada T, Song M, da Silva A, Kosumi K, Gu M, Shi Y, Li W, Liu L, et al. Tumor PDCD1LG2 (PD-L2) expression and the lymphocytic reaction to colorectal cancer. Cancer Immunol Res. 2017;5(11):1046\u201355.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"1395_CR80","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/hep.32383","volume":"76","author":"H Wang","year":"2022","unstructured":"Wang H, Zhang B, Li R, Chen J, Xu G, Zhu Y, Li J, Liang Q, Hua Q, Wang L, et al. KIAA1199 drives immune suppression to promote colorectal cancer liver metastasis by modulating neutrophil infiltration. Hepatology (Baltimore, MD). 2022;76(4):967\u201381.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"3","key":"1395_CR81","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","volume":"76","author":"JH Cha","year":"2019","unstructured":"Cha JH, Chan LC, Li CW, Hsu JL, Hung MC. Mechanisms controlling PD-L1 expression in cancer. Mol Cell. 2019;76(3):359\u201370.","journal-title":"Mol Cell"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01395-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-022-01395-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01395-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T11:05:21Z","timestamp":1668337521000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-022-01395-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1186\/s12920-022-01395-6","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,12]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declares that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}